A registry for patients with lymphoma
AGMT Austrian Lymphoma Registry
This study is collecting information from lymphoma patients to see how they are diagnosed, treated, and how they do over time, all while making sure their regular care isn't affected.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 4000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Arbeitsgemeinschaft medikamentoese Tumortherapie Academic / other |
| Locations | 1 site (Salzburg, State of Salzburg) |
| Trial ID | NCT06294652 on ClinicalTrials.gov |
What this trial studies
This international multicenter observational cohort registry collects data on patients with lymphoma, focusing on their clinical presentation, diagnostic tests, treatment, and longitudinal follow-up regarding survival and tumor progression. Data is extracted from existing medical charts, ensuring that participation does not interfere with standard treatment routines. Each patient is assigned a unique identifier to maintain confidentiality, and informed consent is required prior to data entry.
Who should consider this trial
Good fit: Ideal candidates for this registry are patients aged 18 and older diagnosed with any type of lymphoma.
Not a fit: Patients who are under 18 years old or do not have a diagnosis of lymphoma will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of lymphoma outcomes and improve treatment strategies for patients.
How similar studies have performed: Other observational registries have successfully contributed to the understanding and management of various cancers, indicating that this approach is both valid and beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The registry will include patients ≥ 18 years with lymphoma. Exclusion Criteria: * There are no specific exclusion criteria.
Where this trial is running
Salzburg, State of Salzburg
- Universitätsklinik für Innere Medizin III, PMU Salzburg — Salzburg, State of Salzburg, Austria (Recruiting)
Study contacts
- Principal investigator: Richard Greil, MD — Department of Internal Medicine III, Paracelsus Medical University Salzburg, Salzburg, Austria
- Study coordinator: Daniela Wolkersdorfer, Dr.
- Email: office@agmt.at
- Phone: +436626404412
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.